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were further isolated by chromatography upon soybean trypsin inhibitor agarose as will be described later. The extinction coefficients at 280 nmol/L of BXa and BXa(-GD) were assumed to be 10.0. LACI(HG2) was isolated from HepG2 cell serum-free conditioned media as previously described" or by using a modification of this procedure.22
It has an apparent mol wt of 38,000 by SDS-PAGE and a specific activity of 9,800 to 10,500 IF inhibitory U/mg protein where I unit of activity was defined as that present in 1 mL normal pooled human serum and the extinction coefficient at 280 nmol/L for LACI was assumed to be E (extinction coefficient) 1%/I cm -10." Unless otherwise noted, the LACI(HG2) used in the following experiments was diluted to a concentration of I ig/mL in 0.1 mol/L NaCl, 0.05 mol/L Iris-HCI, pH 7.5, 0.02% NaN3, and I mg/mL BSA (TBSA) and dialzyed overnight against 4,000 vol of 0.1 mol/L NaC1, 0.05 mol/L Tris-HCI, pH 7.5, and 0.02% NaN3.
''I-labeled proteins. 
Thrombin inhibition by LACI(HG2).
Reaction mixtures contaming LACI(HG2) (400 ng/mL) and thrombin (0.5 U/mL, 180 ng/mL) were incubated at room temperature in TBSA. At various time points a subsample was added to 100 L of 0.15 mol/L NaCI, 6.6 g/L polyethylene glycol 6000, 10 mmol/L imidazole, and 10 mmol/L CaC12, pH 7.4, warmed to 37#{176}C. Fifty microliters of fibninogen (2 mg/mL) was then added immediately and the time to clot formation determined on a fibrometer. Relative thrombin activity was determined by using a standard curve constructed with dilutions of thrombin.
Inhibition of TF by LAC!(HG2).
One hundred microlitcrs of a mixture containing VIla (200 ng/mL),
and IF (2% vol/vol) that had been incubated at room temperature for one minute was added to 100 iL TBSA containing LACI(HG2) (600 ng/mL) with or without antithrombin lila (130 i.tg/mL), and heparin ( 1 U/mL). At specified time points thereafter, a l0-iL sample was removed and diluted 100-fold into TBSA with 5 mol/L CaCl2. Due to practical considerations, the diluted samples made from earlier time points were held until the final, one-minute, sample had been obtained, and then all were assayed for residual IF activity by using a two-stage assay. Fifty microliters factor VIla (1 ig/mL), 50 L CaCl2 (25 mmol/L) 50 tL diluted sample, and 50 iL human factor X (10 g g/mL)
were incubated at 37#{176}C. After one minute, 50 iL of a mixture containing ten parts factor X-defIcient plasma and one part rabbit brain cephalin stock reagent (prepared as described by Sigma) was added, and the time to clot formation was determined with a fibrometer. and TF (2% vol/vol). After ten minutes a sample was removed and diluted 100-fold in TBSA plus 5 mmol/L CaC12. Fifty microliters of the diluted sample was then incubated with 50 iL VIIa (1 zg/mL), 50 jzL X (10 g/mL), and 50 iL CaCl2 (25 mmol/L) at 37#{176}C. After one minute, 50 zL of a mixture containing nine parts human factor X-deficient plasma and one part stock rabbit brain cephalin (prepared as described by Sigma) was added and the time to clot formation determined.
A standard curve for LACI activity was constructed by using dilutions of human serum in TBSA and plotting on log-log paper the prolongation of the clotting time above the control (TBSA) level against the concentration of human serum in the first stage of the assay. Because rabbit sera also contains LACI activity that reacts modestly in the human system, additional assays in which rabbit serum without human serum was incubated in the first stage of the assay were also performed to determine the contribution of endogenous rabbit LACI to the total LACI activity measured (-10% (Fig 3) . 
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